Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – EurekAlert
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
IMAGE: Volker M. Lauschke, associate professor
Department of Physiology and Pharmacology, Karolinska Institutet.
view more
Credit: Jannis Politidis
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing…
-
Noosa News14 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News15 hours agoMotorcyclist dies in crash with truck
-
Noosa News16 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General21 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging